Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01694615 · ClinicalTrials.gov registry record · NA

Cryoprobe Transbronchial Lung Biopsy in Lung Transplant Patients

A NA study, sponsored by Johns Hopkins University.

Completed
Registry status
NA
Development phase
30
Enrollment target

NCT01694615: Completed NA study, sponsored by Johns Hopkins University.

NCT01694615 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01694615, a NA study, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

Lung transplant recipients undergo bronchoscopy with biopsies for clinical indications and for surveillance in the diagnosis of acute rejection using standard transbronchial forceps. It is recognized that standard forceps biopsies underestimate the presence or degree of airway rejection due to crush artifact and sample size. Transbronchial cryobiopsies have been shown in the literature to provide larger samples without crush artifact in a safe fashion in lung cancer patients. The aim of this study is to determine if transbronchial cryobiopsy is superior to standard transbronchial forceps biopsies in regards to sample size, architecture and the diagnosis of early rejection in lung transplant recipients which if discovered earlier may improve survival.

Interventions

  • PROCEDURE Cryoprobe biopsy
  • PROCEDURE Forceps Biopsy

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2011-11
Est. Completion 2015-09
Phase NA

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT01694615

The ClinicalTrials.gov registry entry for NCT01694615 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Cryoprobe biopsy is the first listed.

NCT01694615 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01694615 about?

NCT01694615 is a clinical study titled "Cryoprobe Transbronchial Lung Biopsy in Lung Transplant Patients". Lung transplant recipients undergo bronchoscopy with biopsies for clinical indications and for surveillance in the diagnosis of acute rejection using standard transbronchial forceps. It is recognized that standard forceps biopsies underestimate the presence or degree of airway rejection due to crush...

What is the current status of trial NCT01694615?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2011-11. Estimated completion is 2015-09.

What interventions are being tested in trial NCT01694615?

The interventions under investigation include: Cryoprobe biopsy (PROCEDURE), Forceps Biopsy (PROCEDURE).

Who is sponsoring clinical trial NCT01694615?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.